title: Determinants of adherence to glaucoma medical therapy in a long-term patient population.
abstract: OBJECTIVE
  Estimate patient adherence to glaucoma medications and identify potential determinants of nonadherence.
  
  
  METHODS
  Descriptive study.
  
  
  METHODS
  Two hundred patients with open angle glaucoma, ocular hypertension, or glaucoma suspects were interviewed regarding their glaucoma and its treatment and their charts were reviewed. Their ophthalmologist completed a brief assessment form. Drug utilization data were extracted from the provincial drug program database. Patients were defined as adherent if they filled at least 75% of the prescribed medication necessary for their treatment.
  
  
  RESULTS
  Data were available for 181 patients. About 62.9% were female and the mean age (+/-SD) was 75.1+/-8.8 years. The mean number of years of glaucoma treatment was 10.7+/-9.3. Self-reported treatment adherence was 88.3%. On the basis of the drug database, the proportion of patients who were adherent to treatment was 71.8%. According to physicians, 74.6% of patients were adherent. Among patients considered by physicians as nonadherent, 71.1% (32/45) were adherent and among patients predicted as adherent, 72.1% (98/136) were adherent. There was no significant difference in adherence according to age, sex, education, and income. However, patients using fewer agents (P=0.041), who were widowed (P=0.041), or who lived alone (P=0.042) were more adherent. Patients using prostaglandins analogs or beta-blockers were more adherent than those using carbonic anhydrase inhibitors (P<0.05).
  
  
  CONCLUSIONS
  Fewer medications, use of prostaglandin analogs or beta-blockers, living alone, and being widowed were significantly associated with adherence. Physicians were unable to significantly predict which patients are adherent.
authors.affiliation: Department of Ophthalmology, University of Montreal, Quebec, Canada.
authors.forename: Fawzia
authors.initials: F
authors.lastname: Djafari
authors.forename: Mark R
authors.initials: MR
authors.lastname: Lesk
authors.forename: Paul J
authors.initials: PJ
authors.lastname: Harasymowycz
authors.forename: Daniel
authors.initials: D
authors.lastname: Desjardins
authors.forename: Jean
authors.initials: J
authors.lastname: Lachaine
mesh_terms: D000368:Aged; D000959:Antihypertensive Agents / Q000008:administration & dosage* / Q000145:classification; D004363:Drug Utilization / Q000706:statistics & numerical data; D005260:Female; D005902:Glaucoma, Open-Angle / Q000188:drug therapy*; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D008297:Male; D009798:Ocular Hypertension / Q000188:drug therapy; D010349:Patient Compliance / Q000706:statistics & numerical data*; D011795:Surveys and Questionnaires
chemical_list: D000959:Antihypertensive Agents